logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Gemcitabine CAS 95058-81-4 API Active Pharmaceutical Ingredient

Gemcitabine CAS 95058-81-4 API Active Pharmaceutical Ingredient

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 95058-81-4

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:

CAS 95058-81-4 Gemcitabine

,

CAS 95058-81-4

CAS NO::
95058-81-4
Appearance::
Solid
Molecular Formula::
C9H11F2N3O4
Molecular Weight::
263.19800
EINECS NO::
619-100-6
MDL NO::
MFCD00869720
CAS NO::
95058-81-4
Appearance::
Solid
Molecular Formula::
C9H11F2N3O4
Molecular Weight::
263.19800
EINECS NO::
619-100-6
MDL NO::
MFCD00869720
Gemcitabine CAS 95058-81-4 API Active Pharmaceutical Ingredient

Product Description:

Product Name: Gemcitabine CAS NO: 95058-81-4                     


Synonyms:

4-AMINO-1-[(2R,4R,5R)-3,3-DIFLUORO-4-HYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL]PYRIMIDIN-2-ONE;

GEMCITABINE HCL;

GEMCITABINE, FREE BASE;


Chemical & Physical Properties:

Appearance: Solid

Assay :≥99.0%

Density: 1.84±0.1 g/cm3(Predicted)

Flash Point: 236.8±31.5℃

Melting Point: 168.64℃

Boiling Point: 482.7±55.0℃(Predicted)

Vapor Pressure: 0.0±2.6 mmHg at 25℃

Index of Refraction: 1.652


Safety Information:

Safety Statements: S25; S26; S36/37; S53

Risk Statements: R21; R36/38; R46; R62; R63

Hazard Codes: Xn,Xi

HS Code: 29349990


Gemcitabine (pronunciation: jem-SITE-a-been) is a nucleoside analog used as chemotherapy. It is marketed as Gemzar by Eli Lilly and Company.

It is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system. Gemcitabine(Gemzar) belongs to the group of medicines called antimetabolites. It is used alone or in combination with other medicines to treat cancer of the breast, ovary, pancreas, and lung.


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.